Article

New supplement targets diabetic retinopathy

A new supplement (Diabetic Vision Formula, EyeScience Labs) is designed to help protect against potential vision problems associated with diabetic retinopathy.

Columbus, OH-A new supplement (Diabetic Vision Formula, EyeScience Labs) is designed to help protect against potential vision problems associated with diabetic retinopathy.

“The [product] was formulated to help target the oxidative stress that can negatively [affect] the blood vessel system in the eyes for people [who] live with diabetes,” said Jeff Northup, president and chief executive officer of EyeScience Labs. He added that the product is the result of extensive research and clinical studies.

Among the formulation’s ingredients are vitamin B6, omega-3 fatty acids, niacin, lutein, alpha lipoic acid, cinnamon bark, bilberry, and grape seed extract.

“Together, these powerful carotenoid antioxidants and other essential nutritional ingredients can help support healthy ocular blood vessels,” Northrup said.

The company’s products are sold directly through participating eye-care professionals and nationwide at any CVS Pharmacy. For more information, contact EyeScience at 877/393-8482 or visit www.EyeScience.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.